BridgeBio Pharma Overview
BridgeBio Pharma Target Price
Analysts' 12-month price predictions for BBIO.
Get informed when a big investor buys or sells
+ FollowShare Price
$84.09
Average Target Price
$106.75
26.9% upside
26.9% upside8 analysts in the last 4 months
High: $130 | Low: $96
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-16 | Mizuho SecuritiesSalim Syed | $96 | 14.2% upside |  |
| 2026-06-03 | Canaccord Genuity | $104 | 23.7% upside | |
| 2026-05-28 | Morgan Stanley | $98 | 16.5% upside | |
| 2026-05-11 | H.C. Wainwright | $110 | 30.8% upside | |
| 2026-05-08 | Evercore ISI | $130 | 54.6% upside | |
| 2026-05-08 | Bernstein | $114 | 35.6% upside | |
| 2026-04-29 | Truist FinancialDanielle Brill | $102 | 21.3% upside | |
| 2026-04-08 | RBC CapitalLuca Issi | $100 | 18.9% upside | |
| 2026-03-12 | Leerink PartnersMani Foroohar | $98 | 16.5% upside | |
| 2026-02-25 | Truist FinancialDanielle Brill | $95 | 13% upside | |
| 2026-02-17 | H.C. WainwrightRaghuram Selvaraju | $100 | 18.9% upside | |
| 2026-02-13 | Tudor PickeringWilliam Pickering | $100 | 18.9% upside | |
| 2026-02-13 | OppenheimerTrevor Allred | $83 |  1.3% downside | |
| 2026-02-12 | JefferiesAndrew Tsai | $100 | 18.9% upside | |
| 2026-02-12 | Raymond JamesMartin Auster | $89 | 5.8% upside | |
| 2026-01-27 | Barclays | $157 | 86.7% upside | |
| 2026-01-20 | Wells FargoTiago Fauth | $88 | 4.6% upside | |
| 2026-01-08 | Truist Financial | $86 | 2.3% upside | |
| 2026-01-06 | Morgan Stanley | $96 | 14.2% upside | |
| 2025-12-15 | Leerink Partners | $86 | 2.3% upside | |
| 2025-12-11 | Bernstein | $94 | 11.8% upside | |
| 2025-10-30 | Truist Financial | $80 | 4.9% downside | |
| 2025-10-30 | Oppenheimer | $81 | 3.7% downside | |
| 2025-10-30 | Piper Sandler | $98 | 16.5% upside | |
| 2025-10-30 | Goldman SachsPaul Choi | $100 | 18.9% upside | |
| 2025-10-29 | H.C. Wainwright | $90 | 7% upside | |
| 2025-10-28 | H.C. Wainwright | $80 | 4.9% downside | |
| 2025-10-27 | Raymond James | $69 | 17.9% downside | |
| 2025-10-27 | Leerink PartnersMani Foroohar | $68 | 19.1% downside | |
| 2025-08-29 | H.C. WainwrightRaghuram Selvaraju | $70 | 16.8% downside | |
| 2025-04-30 | UBSEliana Merle | $72 | 14.4% downside | |
| 2024-10-24 | CitigroupDavid Lebowitz | $45 | 46.5% downside | |
| 2024-10-17 | Leerink PartnersMani Foroohar | $46 | 45.3% downside | |
| 2024-09-11 | Piper SandlerBiren Amin | $46 | 45.3% downside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $53 | 37% downside | |
| 2024-06-24 | Raymond JamesDanielle Brill | $46 | 45.3% downside | |
| 2024-06-05 | BMO CapitalKostas Biliouris | $37 | 56% downside | |
| 2024-06-05 | Wells FargoTiago Fauth | $58 | 31% downside | |
| 2024-05-30 | Goldman SachsPaul Choi | $50 | 40.5% downside | |
| 2024-05-28 | UBSEliana Merle | $47 | 44.1% downside | |
| 2024-05-20 | H.C. WainwrightRaghuram Selvaraju | $43 | 48.9% downside | |
| 2024-05-13 | Evercore ISICory Kasimov | $50 | 40.5% downside | |
| 2022-11-18 | J.P. Morgan | $19 | 77.4% downside | |
| 2022-03-17 | Raymond JamesDane Leone | $17 | 79.8% downside | |